MDMA Joins Coalition Letter in Urging Sensible Patent Reform

MDMA joined with several national and regional associations and companies in sending a letter to the House of Representatives as they begin work on patent reform legislation.

The Senate recently passed its version of this important legislation, and the House is in the process of working on a bill that if passed, will have to be reconciled with the Senate version before becoming law.

MDMA and the other signatories noted that it is crucial for innovation and intellectual property protections that there are safeguards against abuse in any legislative expansion of the post-grant administrative review system.  The letter, sent to the Chairman and Ranking Member of the House Judiciary Committee, noted that “Too often during the debate over patent legislation, policymakers have focused narrowly on increasing the ability to knock out bad patents without regard for the collateral damage that could be inflicted on good patents as a result.”

To view of copy of the letter, click below.